<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Whistleblowerlaws</title>
	<atom:link href="http://www.whistleblowerlaws.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.whistleblowerlaws.com</link>
	<description>The Source for Whistleblowers</description>
	<lastBuildDate>Tue, 11 Jun 2013 19:34:53 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
		<item>
		<title>Trying a False Claims Act Case</title>
		<link>http://www.whistleblowerlaws.com/trying-a-false-claims-act-case/</link>
		<comments>http://www.whistleblowerlaws.com/trying-a-false-claims-act-case/#comments</comments>
		<pubDate>Tue, 11 Jun 2013 19:34:53 +0000</pubDate>
		<dc:creator>David Fischer</dc:creator>
				<category><![CDATA[Featured]]></category>
		<category><![CDATA[Whistleblowers Blog]]></category>
		<category><![CDATA[Whistleblowing]]></category>

		<guid isPermaLink="false">http://www.whistleblowerlaws.com/?p=2343</guid>
		<description><![CDATA[I had the distinct honor of planning, serving on the faculty for, and attending the ABA National False Claims Act and Qui Tam Trial Institute on June 5-7.  The Trial Institute was fun, interesting, engaging and illustrated the trying a False Claims Act case is not as hard it might appear. Over the last several [...]]]></description>
		<wfw:commentRss>http://www.whistleblowerlaws.com/trying-a-false-claims-act-case/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Chase the individual, not the firm</title>
		<link>http://www.whistleblowerlaws.com/chase-the-individual-not-the-firm/</link>
		<comments>http://www.whistleblowerlaws.com/chase-the-individual-not-the-firm/#comments</comments>
		<pubDate>Mon, 03 Jun 2013 17:13:25 +0000</pubDate>
		<dc:creator>Reuben Guttman</dc:creator>
				<category><![CDATA[Whistleblowers Blog]]></category>

		<guid isPermaLink="false">http://www.whistleblowerlaws.com/?p=2338</guid>
		<description><![CDATA[With some companies seeing fines as a fee for law breaking, is it time to pursue the individuals? It seems that every day brings new revelations of corporate fraud leaving shareholders at a loss, workers without jobs and consumers victimised. The epidemic is not limited to a specific industrial sector. Take your pick: from pharmaceuticals [...]]]></description>
		<wfw:commentRss>http://www.whistleblowerlaws.com/chase-the-individual-not-the-firm/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Is Ranbaxy the Tip of the Iceberg?</title>
		<link>http://www.whistleblowerlaws.com/is-ranbaxy-the-tip-of-the-iceberg/</link>
		<comments>http://www.whistleblowerlaws.com/is-ranbaxy-the-tip-of-the-iceberg/#comments</comments>
		<pubDate>Wed, 22 May 2013 21:12:36 +0000</pubDate>
		<dc:creator>Reuben Guttman</dc:creator>
				<category><![CDATA[Whistleblowers Blog]]></category>

		<guid isPermaLink="false">http://www.whistleblowerlaws.com/?p=2334</guid>
		<description><![CDATA[As a result of a 2007 lawsuit initiated by a whistleblower under the U.S. Federal False Claims Act, Ranbaxy USA, Inc., a subsidiary of Indian generic pharmaceutical manufacture Ranbaxy Laboratories, Ltd., has agreed to pay the United States Government and multiple state governments the sum of $350 million to resolve civil claims. Ranbaxy USA also [...]]]></description>
		<wfw:commentRss>http://www.whistleblowerlaws.com/is-ranbaxy-the-tip-of-the-iceberg/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Psychic Investing</title>
		<link>http://www.whistleblowerlaws.com/psychic-investing/</link>
		<comments>http://www.whistleblowerlaws.com/psychic-investing/#comments</comments>
		<pubDate>Mon, 20 May 2013 13:11:37 +0000</pubDate>
		<dc:creator>David Fischer</dc:creator>
				<category><![CDATA[Whistleblower Articles]]></category>
		<category><![CDATA[Whistleblower News]]></category>
		<category><![CDATA[Whistleblowers Blog]]></category>
		<category><![CDATA[Whistleblowing]]></category>

		<guid isPermaLink="false">http://www.whistleblowerlaws.com/?p=2318</guid>
		<description><![CDATA[This post was written by our own Justin Victor. Last month the SEC announced that it had filed a civil action against Sean Morton, an individual who engaged in a multi-million dollar investment scheme premised on Mr. Morton’s self-proclaimed psychic abilities.  Mr. Morton solicited potential investors in one of his several investment companies claiming that [...]]]></description>
		<wfw:commentRss>http://www.whistleblowerlaws.com/psychic-investing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>If You Cannot Change Label, Change The Guidelines</title>
		<link>http://www.whistleblowerlaws.com/if-you-cannot-change-label-change-the-guidelines/</link>
		<comments>http://www.whistleblowerlaws.com/if-you-cannot-change-label-change-the-guidelines/#comments</comments>
		<pubDate>Fri, 17 May 2013 14:46:11 +0000</pubDate>
		<dc:creator>David Fischer</dc:creator>
				<category><![CDATA[Federal False Claims Acts]]></category>
		<category><![CDATA[Whistleblower Articles]]></category>
		<category><![CDATA[Whistleblower News]]></category>
		<category><![CDATA[Whistleblowers Blog]]></category>

		<guid isPermaLink="false">http://www.whistleblowerlaws.com/?p=2329</guid>
		<description><![CDATA[The Washington Post has a lengthy article in today’s paper regarding the extensive financial ties and conflicts of interest between the American Psychiatric Association (APA), the publisher of the Diagnostic and Statistical Manual of Mental Disorders (DSM), and the pharmaceutical industry.  Pharmaceutical companies have given substantial sums of money to the publisher as well as [...]]]></description>
		<wfw:commentRss>http://www.whistleblowerlaws.com/if-you-cannot-change-label-change-the-guidelines/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Off-Label Marketing After The Settlement</title>
		<link>http://www.whistleblowerlaws.com/off-label-marketing-after-the-settlement/</link>
		<comments>http://www.whistleblowerlaws.com/off-label-marketing-after-the-settlement/#comments</comments>
		<pubDate>Mon, 06 May 2013 21:23:48 +0000</pubDate>
		<dc:creator>David Fischer</dc:creator>
				<category><![CDATA[Federal False Claims Acts]]></category>
		<category><![CDATA[Whistleblower Articles]]></category>
		<category><![CDATA[Whistleblowers Blog]]></category>
		<category><![CDATA[Whistleblowing]]></category>

		<guid isPermaLink="false">http://www.whistleblowerlaws.com/?p=2323</guid>
		<description><![CDATA[The Los Angeles Times recently reported that off-label uses of modafinil has continued to rise a very rapid rate.  Following up on a report in JAMA Internal Medicine, the LA Times reports: &#8230; a group of researchers has shown that use of modafinil grew almost ten-fold between 2002 and 2009, with the steepest rise in [...]]]></description>
		<wfw:commentRss>http://www.whistleblowerlaws.com/off-label-marketing-after-the-settlement/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Foreign Whistleblowers Hold Multi-Nationals Accountable and Get Rewarded For Their Efforts</title>
		<link>http://www.whistleblowerlaws.com/foreign-whistleblowers-hold-multi-nationals-accountable-and-get-rewarded-for-their-efforts/</link>
		<comments>http://www.whistleblowerlaws.com/foreign-whistleblowers-hold-multi-nationals-accountable-and-get-rewarded-for-their-efforts/#comments</comments>
		<pubDate>Mon, 06 May 2013 13:24:23 +0000</pubDate>
		<dc:creator>David Fischer</dc:creator>
				<category><![CDATA[Whistleblower Articles]]></category>
		<category><![CDATA[Whistleblower News]]></category>
		<category><![CDATA[Whistleblowers Blog]]></category>
		<category><![CDATA[Whistleblowing]]></category>

		<guid isPermaLink="false">http://www.whistleblowerlaws.com/?p=2315</guid>
		<description><![CDATA[This post was written by our own Justin Victor. HELP WANTED! The United States government is seeking the help of individuals who have information about multi-national companies that pay bribes to foreign officials to get business, or cheat the United States out of taxes or the benefit of bargained for products or services. Those interested [...]]]></description>
		<wfw:commentRss>http://www.whistleblowerlaws.com/foreign-whistleblowers-hold-multi-nationals-accountable-and-get-rewarded-for-their-efforts/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Q&amp;A: Whistle-blower lawyer on Amgen settlement, False Claims Act</title>
		<link>http://www.whistleblowerlaws.com/qa-whistle-blower-lawyer-on-amgen-settlement-false-claims-act/</link>
		<comments>http://www.whistleblowerlaws.com/qa-whistle-blower-lawyer-on-amgen-settlement-false-claims-act/#comments</comments>
		<pubDate>Thu, 18 Apr 2013 16:18:33 +0000</pubDate>
		<dc:creator>Reuben Guttman</dc:creator>
				<category><![CDATA[Whistleblower News]]></category>

		<guid isPermaLink="false">http://www.whistleblowerlaws.com/?p=2306</guid>
		<description><![CDATA[This interview with Reuben Guttman was conducted by journalist Terry Baynes with Thomson Reuters. California-based drugmaker Amgen Inc agreed on Tuesday to pay $24.9 million to settle allegations that it provided kickbacks to long-term care pharmacy providers to entice them to switch patients to its anemia drug Aranesp. Whistle-blower Frank Kurnik, a longtime Amgen employee, [...]]]></description>
		<wfw:commentRss>http://www.whistleblowerlaws.com/qa-whistle-blower-lawyer-on-amgen-settlement-false-claims-act/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The False Claims Act, Foreign Made Goods And Antidumping Duties</title>
		<link>http://www.whistleblowerlaws.com/the-false-claims-act-foreign-made-goods-and-antidumping-duties/</link>
		<comments>http://www.whistleblowerlaws.com/the-false-claims-act-foreign-made-goods-and-antidumping-duties/#comments</comments>
		<pubDate>Wed, 17 Apr 2013 19:25:18 +0000</pubDate>
		<dc:creator>David Fischer</dc:creator>
				<category><![CDATA[Federal False Claims Acts]]></category>
		<category><![CDATA[Whistleblower News]]></category>
		<category><![CDATA[Whistleblowers Blog]]></category>
		<category><![CDATA[Whistleblowing]]></category>

		<guid isPermaLink="false">http://www.whistleblowerlaws.com/?p=2303</guid>
		<description><![CDATA[Two recent False Claims Act cases involving foreign made goods highlight the role of the False Claims Act when foreign made goods are sold to the United States government.  The first case involved the sale of goods made in China to the government.   In late March, the government and CDW-government (“CDW-G”) settled a False Claims [...]]]></description>
		<wfw:commentRss>http://www.whistleblowerlaws.com/the-false-claims-act-foreign-made-goods-and-antidumping-duties/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>$24.9 Million Settlement with Biotechnology Company Amgen, Inc. Resolves South Carolina False Claims Act Lawsuit</title>
		<link>http://www.whistleblowerlaws.com/24-9-million-settlement-with-biotechnology-company-amgen-inc-resolves-south-carolina-false-claims-act-lawsuit/</link>
		<comments>http://www.whistleblowerlaws.com/24-9-million-settlement-with-biotechnology-company-amgen-inc-resolves-south-carolina-false-claims-act-lawsuit/#comments</comments>
		<pubDate>Tue, 16 Apr 2013 21:36:57 +0000</pubDate>
		<dc:creator>Reuben Guttman</dc:creator>
				<category><![CDATA[Whistleblower News]]></category>

		<guid isPermaLink="false">http://www.whistleblowerlaws.com/?p=2273</guid>
		<description><![CDATA[PRESS NOTICE BILL NETTLES UNITED STATES ATTORNEY DISTRICT OF SOUTH CAROLINA 1441 Main Street, Suite 500 * Columbia, SC 29201 * (803) 929-3000 April 16, 2013 FOR IMMEDIATE RELEASE CONTACT PERSON: Fran Trapp (803) 929-3000 Fran.Trapp@usdoj.gov COLUMBIA, South Carolina &#8212;-United States Attorney Bill Nettles announced a $24.9 million settlement with Amgen, Inc., a California based [...]]]></description>
		<wfw:commentRss>http://www.whistleblowerlaws.com/24-9-million-settlement-with-biotechnology-company-amgen-inc-resolves-south-carolina-false-claims-act-lawsuit/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
